Sep 9, 2021 - Economy & Business

Solugen, developer of plant-derived chemicals, raises $350 million

Illustration of a plant potter.
Illustration: Eniola Odetunde/Axios

Solugen, a Houston-based developer of plant-derived chemicals, raised $350 million in Series C funding at a $1.5 billion pre-money valuation co-led by Baillie Gifford and GIC.

Why it matters: This is a new front in the decarbonization battle, given the dominance of petroleum-based chemicals. Solugen says the big dollars will help it build "bioforges" around the world, adding that they're cheaper and take less time to build than do typical petrochemical or fermentation plants.

The bottom line: Solugen is basically trying to apply Moore's Law to scaling chemical production, marrying microbe design with process tech.

Go deeper